Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2007 | 06-2007 | 03-2007 | 12-2006 | 09-2006 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 4,410 | 3,020 | 2,290 | 2,050 | 2,120 |
| TOTAL | $4,410 | $3,020 | $2,290 | $2,050 | $2,120 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 64,790 | 57,920 | 59,120 | 63,360 | 64,340 |
| TOTAL | $64,790 | $57,920 | $59,120 | $63,360 | $64,340 |
| Total Assets | $69,200 | $60,940 | $61,410 | $65,410 | $66,460 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,600 | 4,280 | 3,850 | 3,590 | 680 |
| Accounts payable and accrued liabilities | 17,430 | 15,960 | 12,960 | 13,390 | 11,380 |
| Other current liabilities | 8,840 | 5,700 | 5,530 | 8,890 | 6,280 |
| TOTAL | $34,220 | $25,940 | $22,340 | $25,870 | $18,340 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 28,470 | 23,760 | 24,120 | 22,680 | 24,320 |
| TOTAL | $28,470 | $23,760 | $24,120 | $22,680 | $24,320 |
| Total Liabilities | $62,690 | $49,700 | $46,460 | $48,550 | $42,660 |
| Shareholders' Equity | |||||
| Common Shares | 70 | 70 | 70 | 60 | 60 |
| Other shareholders' equity | 1,430 | -7,830 | -8,150 | -720 | -5,210 |
| TOTAL | $440,870 | $430,990 | $429,080 | $428,310 | $422,610 |
| Total Liabilities And Equity | $503,560 | $480,690 | $475,540 | $476,860 | $465,270 |